These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19715050)

  • 21. [Statins and cardiovascular disease prevention: use and prospective].
    Moulin P
    Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary prevention with over-the-counter statins: a cautionary tale.
    Davidoff F
    Clin Pharmacol Ther; 2005 Sep; 78(3):218-20. PubMed ID: 16153392
    [No Abstract]   [Full Text] [Related]  

  • 23. The healthy adherer effect.
    Andersohn F; Willich SN
    Arch Intern Med; 2009 Sep; 169(17):1635-6; author reply 1636. PubMed ID: 19786686
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins and primary prevention of cardiovascular events.
    Donner-Banzhoff N; Sönnichsen A
    BMJ; 2008 Nov; 337():a2576. PubMed ID: 19010973
    [No Abstract]   [Full Text] [Related]  

  • 25. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins as cardioprotective agents.
    Piskur JR; Stone NJ
    Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325
    [No Abstract]   [Full Text] [Related]  

  • 27. Statins. Evidence of effectiveness in older patients.
    Nash DT
    Geriatrics; 2003 May; 58(5):35-6, 39-42. PubMed ID: 12756679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-specific aspects of cardiovascular disease.
    Roberts BH
    Med Health R I; 2005 Oct; 88(10):339-41. PubMed ID: 16350933
    [No Abstract]   [Full Text] [Related]  

  • 29. [Statins in older patients: limits to prescription?].
    Bosshard Taroni W; Büla C; Darioli R
    Rev Med Suisse; 2005 Nov; 1(39):2512-4, 2516-7. PubMed ID: 16323731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Summaries of nursing care-related systematic reviews from the Cochrane library: statins for the primary prevention of cardiovascular disease.
    Li J; Zhou L
    J Cardiovasc Nurs; 2011; 26(4):288-9. PubMed ID: 21666420
    [No Abstract]   [Full Text] [Related]  

  • 31. Using statins to reduce cardiovascular risk after carotid endarterectomy.
    Floros G; Anagnostou V; Tsiga E; Ferenidou F; Papadimitriou D
    Evid Based Cardiovasc Med; 2006 Mar; 10(1):1-4. PubMed ID: 16530653
    [No Abstract]   [Full Text] [Related]  

  • 32. [The JUPITER study emphasizes primary prevention].
    Olsson AG
    Lakartidningen; 2009 Jun 3-9; 106(23):1577. PubMed ID: 19583019
    [No Abstract]   [Full Text] [Related]  

  • 33. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Statins in chronic renal disease].
    Ferreira SR; Rocha AM; Saraiva JF
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.
    Packard C
    Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary prevention using statins: to be or not to be?
    Breimer LH; Mikhailidis DP
    Curr Med Res Opin; 2010 Nov; 26(11):2701-6. PubMed ID: 20954857
    [No Abstract]   [Full Text] [Related]  

  • 37. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W; Gmiński J
    Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bad medicine: statins.
    Spence D
    BMJ; 2013 May; 346():f3566. PubMed ID: 23729321
    [No Abstract]   [Full Text] [Related]  

  • 40. The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.
    Friedewald VE; Ballantyne CM; Davidson MH; Guyton JR; Roberts WC
    Am J Cardiol; 2008 Sep; 102(5):559-67. PubMed ID: 18721512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.